6-amino-1-hydroxyhexane-1,1-diphosphonate and Back Ache

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Back Ache in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baldini, M; Borgna Pignatti, C; Cappellini, MD; D'Ascola, DG; Filosa, A; Forni, GL; Giusti, A; Iolascon, G; Nobili, B; Palummeri, E; Perrotta, S; Pinto, V; Pitrolo, L; Quarta, G; Rigano, P; Rosa, A	1

Trials

1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Back Ache

Article	Year
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study. British journal of haematology, 2012, Volume: 158, Issue:2 Topics: Adolescent; Adult; Alkaline Phosphatase; Back Pain; beta-Thalassemia; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type I; Diphosphonates; Female; Femur Neck; Hip Joint; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Peptides; Quality of Life; Treatment Outcome; Young Adult	2012

Article

Year

Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.

British journal of haematology, 2012, Volume: 158, Issue:2

Topics: Adolescent; Adult; Alkaline Phosphatase; Back Pain; beta-Thalassemia; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Collagen Type I; Diphosphonates; Female; Femur Neck; Hip Joint; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Peptides; Quality of Life; Treatment Outcome; Young Adult

2012